| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Varshesh Shah, Rajesh Alugolu, Abhishek Arora, Rukmini M Kandadai, Vijayasaradhi Mudumba, Rupam Borgohai. 3T MRI-SWI based volumetric analysis of the subthalamic and red nuclei in advanced Parkinson's disease. Journal of neurosurgical sciences. 2020-05-13. PMID:32401475. |
parkinson's disease (pd) is a neurodegenerative disease mainly involving the dopaminergic neurons of the substantia nigra. |
2020-05-13 |
2023-08-13 |
Not clear |
| Shima Tavakol, Elham Hoveizi, Behnaz Tavakol, Fereshteh Azedi, Somayeh Ebrahimi-Barough, Peyman Keyhanvar, Mohammad Taghi Joghatae. Small molecule of sphingosine as a rescue of dopaminergic cells: A cell therapy approach in neurodegenerative diseases therapeutics. Journal of cellular physiology. vol 234. issue 7. 2020-05-12. PMID:30623407. |
small molecule of sphingosine as a rescue of dopaminergic cells: a cell therapy approach in neurodegenerative diseases therapeutics. |
2020-05-12 |
2023-08-13 |
Not clear |
| Mustafa T Ardah, Madiha Mohieldin Merghani, M Emdadul Haqu. Thymoquinone prevents neurodegeneration against MPTP in vivo and modulates α-synuclein aggregation in vitro. Neurochemistry international. vol 128. 2020-04-24. PMID:31028778. |
parkinson's disease (pd) is a common neurodegenerative disease characterized by progressive dopaminergic neurodegeneration with a concomitant increase in oxidative stress and neuroinflammation in the substantia nigra pars compacta (snc). |
2020-04-24 |
2023-08-13 |
mouse |
| Hideaki Matsui, Naoya Kenmochi, Kazuhiko Namikaw. Age- and α-Synuclein-Dependent Degeneration of Dopamine and Noradrenaline Neurons in the Annual Killifish Nothobranchius furzeri. Cell reports. vol 26. issue 7. 2020-04-21. PMID:30759385. |
parkinson's disease (pd) is a neurodegenerative disease characterized by α-synuclein-positive inclusion bodies and loss of neurons, including dopaminergic neurons. |
2020-04-21 |
2023-08-13 |
human |
| Pei-Cih Wei, Guey-Jen Lee-Chen, Chiung-Mei Chen, Yih-Ru Wu, Yi-Jing Chen, Jia-Li Lin, Yen-Shi Lo, Ching-Fa Yao, Kuo-Hsuan Chan. Neuroprotection of Indole-Derivative Compound NC001-8 by the Regulation of the NRF2 Pathway in Parkinson's Disease Cell Models. Oxidative medicine and cellular longevity. vol 2019. 2020-04-20. PMID:31781339. |
parkinson's disease (pd) is a common neurodegenerative disease accompanied by a loss of dopaminergic (daergic) neurons. |
2020-04-20 |
2023-08-13 |
Not clear |
| Eunju Lee, Inhwa Hwang, Sangjun Park, Sujeong Hong, Boreum Hwang, Yoeseph Cho, Junghyun Son, Je-Wook Y. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration. Cell death and differentiation. vol 26. issue 2. 2020-04-07. PMID:29786072. |
parkinson's disease (pd) is a progressive neurodegenerative disease characterized by the loss of dopaminergic neurons in the substantia nigra (sn) and the reduction of dopamine levels in the striatum. |
2020-04-07 |
2023-08-13 |
mouse |
| Laís M Cabral, Thiago S Moreira, Ana C Takakura, Bárbara Falquett. Attenuated baroreflex in a Parkinson's disease animal model coincides with impaired activation of non-C1 neurons. Autonomic neuroscience : basic & clinical. vol 225. 2020-03-24. PMID:32092676. |
orthostatic hypotension is one of the most common symptoms observed in parkinson's disease (pd), a neurodegenerative disease caused by death of dopaminergic neurons in the substantia nigra pars compacta (snc), and it is associated with denervation of the heart and impairment of the baroreflex. |
2020-03-24 |
2023-08-13 |
rat |
| Ruru Li, Jianzong Che. Salidroside Protects Dopaminergic Neurons by Enhancing PINK1/Parkin-Mediated Mitophagy. Oxidative medicine and cellular longevity. vol 2019. 2020-03-20. PMID:31583052. |
parkinson's disease (pd) is a common neurodegenerative disease characterized by the degeneration of nigrostriatal dopaminergic (da) neurons. |
2020-03-20 |
2023-08-13 |
Not clear |
| Himadri Shekhaar Baul, Ceera Manikandan, Dwaipayan Se. Cannabinoid receptor as a potential therapeutic target for Parkinson's Disease. Brain research bulletin. vol 146. 2020-03-10. PMID:30664919. |
parkinson's disease (pd) is the second most prevalent neurodegenerative disease, characterized by the loss of dopaminergic neurons from substantia nigra pars compacta of basal ganglia caused due to gene mutation, misfolded protein aggregation, reactive oxygen species generation and inflammatory stress. |
2020-03-10 |
2023-08-13 |
Not clear |
| Jia Liu, Weijing Liu, Hui Yan. Balancing Apoptosis and Autophagy for Parkinson's Disease Therapy: Targeting BCL-2. ACS chemical neuroscience. vol 10. issue 2. 2020-02-26. PMID:30400738. |
conversely, their imbalance is associated with neurodegenerative diseases such as parkinson's disease (pd), which is characterized by a progressive loss of dopaminergic neurons in the substantia nigra pars compacta. |
2020-02-26 |
2023-08-13 |
Not clear |
| Hanming Ge, Zhongjun Yan, Haochun Zhu, Hang Zha. MiR-410 exerts neuroprotective effects in a cellular model of Parkinson's disease induced by 6-hydroxydopamine via inhibiting the PTEN/AKT/mTOR signaling pathway. Experimental and molecular pathology. vol 109. 2020-02-25. PMID:31067440. |
parkinson's disease (pd) is a chronic neurodegenerative disease characterized by loss of dopaminergic neurons in the substantia nigra. |
2020-02-25 |
2023-08-13 |
Not clear |
| Sujung Yeo, Jongbeom Song, Sabina Li. Acupuncture Inhibits the Increase in Alpha-Synuclein in Substantia Nigra in an MPTP- Induced Parkinsonism Mouse Model. Advances in experimental medicine and biology. vol 1232. 2020-01-08. PMID:31893437. |
parkinson's disease, a progressive neurodegenerative disease, is caused by the loss of dopaminergic neurons in the substantia nigra (sn). |
2020-01-08 |
2023-08-13 |
mouse |
| Achut P Silwal, H Peter L. Mode-Selective Raman Imaging of Dopamine-Human Dopamine Transporter Interaction in Live Cells. ACS chemical neuroscience. vol 9. issue 12. 2019-12-23. PMID:30024721. |
interactions of da, its analogue with dars, or dat have been studied extensively to understand the mechanism of the dopaminergic signaling process and several neurodegenerative diseases, including schizophrenia, parkinson's diseases, addiction, attention deficit hyperactivity disorder, and bipolar disorder. |
2019-12-23 |
2023-08-13 |
human |
| Akira Nakajima, Yasushi Ohizum. Potential Benefits of Nobiletin, A Citrus Flavonoid, against Alzheimer's Disease and Parkinson's Disease. International journal of molecular sciences. vol 20. issue 14. 2019-12-20. PMID:31295812. |
parkinson's disease (pd) is the second most common neurodegenerative disease after ad, and is characterized by early prominent loss of dopaminergic neurons in the substantia nigra pars compacta. |
2019-12-20 |
2023-08-13 |
Not clear |
| Helena Xicoy, Bé Wieringa, Gerard J M Marten. The Role of Lipids in Parkinson's Disease. Cells. vol 8. issue 1. 2019-12-09. PMID:30621069. |
parkinson's disease (pd) is a neurodegenerative disease characterized by a progressive loss of dopaminergic neurons from the nigrostriatal pathway, formation of lewy bodies, and microgliosis. |
2019-12-09 |
2023-08-13 |
Not clear |
| Tao Peng, Xiaoyan Liu, Jingtao Wang, Yu Liu, Zhenqiang Fu, Xingrong Ma, Junmin Li, Guifang Sun, Yangfei Ji, Jingjing Lu, Wencui Wan, Hong L. Long noncoding RNA HAGLROS regulates apoptosis and autophagy in Parkinson's disease via regulating miR-100/ATG10 axis and PI3K/Akt/mTOR pathway activation. Artificial cells, nanomedicine, and biotechnology. vol 47. issue 1. 2019-12-09. PMID:31298038. |
parkinson's disease (pd) is a common age-related neurodegenerative disease resulted from the progressive degeneration of dopaminergic neurons in the pars compacta region of substantia nigra. |
2019-12-09 |
2023-08-13 |
mouse |
| Consiglia Pacelli, Giovannina Rotundo, Lucia Lecce, Marta Menga, Eris Bidollari, Rosella Scrima, Olga Cela, Claudia Piccoli, Tiziana Cocco, Angelo Luigi Vescovi, Gianluigi Mazzoccoli, Jessica Rosati, Nazzareno Capitani. Parkin Mutation Affects Clock Gene-Dependent Energy Metabolism. International journal of molecular sciences. vol 20. issue 11. 2019-12-02. PMID:31195749. |
parkinson's disease (pd) is a chronic neurodegenerative disease characterized by a selective loss of dopaminergic neurons. |
2019-12-02 |
2023-08-13 |
Not clear |
| Xiao-Yan Feng, Jingting Yang, Xiaoli Zhang, Jinxia Zh. Gastrointestinal non-motor dysfunction in Parkinson's disease model rats with 6-hydroxydopamine. Physiological research. vol 68. issue 2. 2019-11-25. PMID:30628835. |
parkinson's disease (pd) is a neurodegenerative disease with a progressive loss of mesencephalic dopaminergic neurons of the substantia nigra (sn). |
2019-11-25 |
2023-08-13 |
rat |
| b' Lled\\xc3\\xb. Dopamine agonists: the treatment for Parkinson\'s disease in the XXI century? Parkinsonism & related disorders. vol 7. issue 1. 2019-11-20. PMID:11008196.' |
dopaminergic agonists, acting directly at the receptor level, would be able to decrease the incidence of these motor complications.in progressive neurodegenerative diseases, such as pd, modification of the rate of disease progression (often referred to as neuroprotection) is currently a highly debated topic. |
2019-11-20 |
2023-08-12 |
Not clear |
| Kiana Rafiepour, Saeed Esmaeili-Mahani, Ali Salehzadeh, Vahid Sheiban. Phytohormone Abscisic Acid Protects Human Neuroblastoma SH-SY5Y Cells Against 6-Hydroxydopamine-Induced Neurotoxicity Through Its Antioxidant and Antiapoptotic Properties. Rejuvenation research. vol 22. issue 2. 2019-11-15. PMID:30091676. |
parkinson's disease (pd) is a destroying and prevalent neurodegenerative disease that is characterized by a progressive death of midbrain dopaminergic neurons. |
2019-11-15 |
2023-08-13 |
human |